188 related articles for article (PubMed ID: 33178666)
21. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability.
Onoue S; Takahashi H; Kawabata Y; Seto Y; Hatanaka J; Timmermann B; Yamada S
J Pharm Sci; 2010 Apr; 99(4):1871-81. PubMed ID: 19827133
[TBL] [Abstract][Full Text] [Related]
22. Microparticles Containing Curcumin Solid Dispersion: Stability, Bioavailability and Anti-Inflammatory Activity.
Teixeira CC; Mendonça LM; Bergamaschi MM; Queiroz RH; Souza GE; Antunes LM; Freitas LA
AAPS PharmSciTech; 2016 Apr; 17(2):252-61. PubMed ID: 26040724
[TBL] [Abstract][Full Text] [Related]
23. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
Shome S; Talukdar AD; Choudhury MD; Bhattacharya MK; Upadhyaya H
J Pharm Pharmacol; 2016 Dec; 68(12):1481-1500. PubMed ID: 27747859
[TBL] [Abstract][Full Text] [Related]
24. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation.
Mohanty C; Sahoo SK
Biomaterials; 2010 Sep; 31(25):6597-611. PubMed ID: 20553984
[TBL] [Abstract][Full Text] [Related]
25. Curcumin Loaded and Co-loaded Nanosystems: A Review from a Biological Activity Enhancement Perspective.
Araya-Sibaja AM; Wilhelm K; González-Aguilar GA; Vega-Baudrit JR; Salazar-López NJ; Domínguez-Avila JA; Navarro-Hoyos M
Pharm Nanotechnol; 2021; 9(2):85-100. PubMed ID: 33371864
[TBL] [Abstract][Full Text] [Related]
26. Design of Curcumin Loaded Carbon Nanodots Delivery System: Enhanced Bioavailability, Release Kinetics, and Anticancer Activity.
Arvapalli DM; Sheardy AT; Allado K; Chevva H; Yin Z; Wei J
ACS Appl Bio Mater; 2020 Dec; 3(12):8776-8785. PubMed ID: 35019553
[TBL] [Abstract][Full Text] [Related]
27. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
Nguyen MH; Yu H; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
[TBL] [Abstract][Full Text] [Related]
28. Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats.
Arora R; Kuhad A; Kaur IP; Chopra K
Eur J Pain; 2015 Aug; 19(7):940-52. PubMed ID: 25400173
[TBL] [Abstract][Full Text] [Related]
29. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.
Ma Z; Wang N; He H; Tang X
J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis.
Wang J; Wang H; Zhu R; Liu Q; Fei J; Wang S
Biomaterials; 2015; 53():475-83. PubMed ID: 25890744
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Water Dispersibility of Curcumin Encapsulated in Alginate-Polysorbate 80 Nano Particles and Bioavailability in Healthy Human Volunteers.
Govindaraju R; Karki R; Chandrashekarappa J; Santhanam M; Shankar AKK; Joshi HK; Divakar G
Pharm Nanotechnol; 2019; 7(1):39-56. PubMed ID: 30666922
[TBL] [Abstract][Full Text] [Related]
32. Enhanced apoptotic effect of curcumin loaded solid lipid nanoparticles.
Vandita K; Shashi B; Santosh KG; Pal KI
Mol Pharm; 2012 Dec; 9(12):3411-21. PubMed ID: 23127155
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.
Shaikh J; Ankola DD; Beniwal V; Singh D; Kumar MN
Eur J Pharm Sci; 2009 Jun; 37(3-4):223-30. PubMed ID: 19491009
[TBL] [Abstract][Full Text] [Related]
34. Formulation and characterization of chitosan encapsulated phytoconstituents of curcumin and rutin nanoparticles.
Ramaswamy S; Dwarampudi LP; Kadiyala M; Kuppuswamy G; Veera Venkata Satyanarayana Reddy K; Kumar CKA; Paranjothy M
Int J Biol Macromol; 2017 Nov; 104(Pt B):1807-1812. PubMed ID: 28668610
[TBL] [Abstract][Full Text] [Related]
35. Conundrum and therapeutic potential of curcumin in drug delivery.
Kumar A; Ahuja A; Ali J; Baboota S
Crit Rev Ther Drug Carrier Syst; 2010; 27(4):279-312. PubMed ID: 20932240
[TBL] [Abstract][Full Text] [Related]
36. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles.
Ban C; Jo M; Park YH; Kim JH; Han JY; Lee KW; Kweon DH; Choi YJ
Food Chem; 2020 Jan; 302():125328. PubMed ID: 31404868
[TBL] [Abstract][Full Text] [Related]
37. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity.
Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S
Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128
[TBL] [Abstract][Full Text] [Related]
38. Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
Maiti P; Plemmons A; Dunbar GL
PLoS One; 2019; 14(12):e0225660. PubMed ID: 31841506
[TBL] [Abstract][Full Text] [Related]
39. Enhanced systemic exposure of saquinavir via the concomitant use of curcumin-loaded solid dispersion in rats.
Kim SA; Kim SW; Choi HK; Han HK
Eur J Pharm Sci; 2013 Aug; 49(5):800-4. PubMed ID: 23748001
[TBL] [Abstract][Full Text] [Related]
40. Zein Nanoparticles Improve the Oral Bioavailability of Curcumin in Wistar Rats.
Brotons-Canto A; González-Navarro CJ; Gil AG; Asin-Prieto E; Saiz MJ; Llabrés JM
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33803271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
